MedPath

SODIUM NITROPRUSSIDE FOR INJECTION

SODIUM NITROPRUSSIDE FOR INJECTION

Approved
DIN Number

02450089

Drug Class

Human

Market Date

Apr 26, 2021

Company
HC

Sterimax Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02450089
AIG Number0110498002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C02DD01 NITROPRUSSIDE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification24:08.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

SODIUM NITROPRUSSIDEActive
Strength: 25 MG / ML
Monograph: SODIUM NITROPRUSSIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.